Colorectal Cancer Coverage from Every Angle
Advertisement
Advertisement

Recent News

FOxTROT Trial: Neoadjuvant Chemotherapy for Operable Colon Cancer
FOLFOXIRI Plus Bevacizumab in Unresectable Coloretcal Cancer: Update From TRIBE2
Fight CRC Publishes Collaborative Summary on Early-Onset Colorectal Cancer
ctDNA May Offer Clues to Prognosis in Patients With Rectal Cancer
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Clinical Practice Guideline on Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer
ASCO 2019: Laparoscopic Versus Open Surgery for Colorectal Liver Metastases
ASCO 2019: Bevacizumab Combination Regimens in Poor-Prognosis Metastatic Colorectal Cancer
Is Early Colorectal Cancer Screening Cost-Effective in Childhood Cancer Survivors?
Can High-Intensity Focused Ultrasound Influence Spread of Colorectal Cancer?
Chronic Opioid Use in Older Colorectal Cancer Survivors
Do Endoscopist Characteristics Impact Colonoscopy Polyp Detection Rates?
Can HER2 Status Predict Response to EGFR-Targeted Therapies in Colorectal Cancer?
Triplet Therapy for BRAF V600E–Mutant Metastatic Colorectal Cancer
Colorectal Cancer’s Genetic Relationship to Other Cancers
Novel Approach to Predicting Adverse and Beneficial Effects of Immunologic Interventions
Is There a Role for Wnt/β‐catenin Modulation in Colorectal Cancer?
Exploring the Connection Between the Gut Microbiome and Colon Cancer
Researchers Identify New Genetic Variants Associated With Colorectal Cancer Risk
AACR 2019: Misdiagnosis, Advanced Disease Common in Young-Onset Colon Cancer
2019 ESMO TAT: Predicting Outcomes With Lung Immune Prognostic Index
Short-Course vs. Long-Course Chemoradiation Therapy for Rectal Cancer
Genetic Variants in Predicting Treatment Outcomes in Colorectal Cancer


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.